{"id":4964,"date":"2026-03-02T11:25:41","date_gmt":"2026-03-02T10:25:41","guid":{"rendered":"https:\/\/we4healthcare.com\/2026\/03\/02\/digital-twins-clinical-trials\/"},"modified":"2026-03-24T12:17:05","modified_gmt":"2026-03-24T11:17:05","slug":"digital-twins-clinical-trials","status":"publish","type":"post","link":"https:\/\/we4healthcare.com\/it\/2026\/03\/02\/digital-twins-clinical-trials\/","title":{"rendered":"Digital twins in Clinical trials: a new way of designing studies"},"content":{"rendered":"<p>In the past year, <strong>Digital twin<\/strong> has become one of the most overused terms in healthcare innovation. It appears in conference slides, CRO strategy decks, and investor presentations, often described as a <em>virtual copy of a patient<\/em>, ready to be tested like an avatar in a simulation. But the reality is less cinematic and far more interesting.<\/p><p>A <strong>Digital twin in clinical research is not a plug-and-play technology,<\/strong> it is a different way of thinking about how evidence is designed.<\/p><p>We are moving from a <strong>linear research model<\/strong> to a <strong>predictive one<\/strong>: where protocols were once built mainly on historical datasets and assumptions, predictive models now allow us to simulate potential outcomes before the first patient is enrolled.<\/p><p>The challenge, however, is not computational power, it is <strong>methodology<\/strong>.<\/p><h2 class=\"wp-block-heading\">What a digital twin actually is in clinical research<\/h2><p>In the clinical trial context, a digital twin is not a visual replica of a patient or an organ. It is a <strong>dynamic mathematical model<\/strong> that integrates multiple layers of data to simulate how patients may respond within a study.<\/p><p>Typically, these models combine three major data streams:<\/p><ul class=\"wp-block-list\"><li><strong>Historical clinical trial data<\/strong>, which represent the collective memory of previous studies and drug development programs.<\/li>\n\n<li><strong>Real-World Evidence (RWE)<\/strong> from sources such as electronic health records, registries, and observational datasets.<\/li>\n\n<li><strong>Biological and contextual variability<\/strong>, capturing physiological parameters and patient-level differences that influence treatment response.<\/li><\/ul><p>The goal is not necessarily to replace traditional control arms, although <strong>synthetic control arms<\/strong> are an emerging area of research.<\/p><p>Instead, the real value lies in <strong>anticipating operational and scientific challenges before they appear in real patients<\/strong>.<\/p><h2 class=\"wp-block-heading\">Why It matters for study design<\/h2><p>For teams designing clinical trials, Digital twin approaches can deliver very concrete advantages.<\/p><h3 class=\"wp-block-heading\">Protocol robustness<\/h3><p>One of the most common reasons for protocol amendments is unrealistic inclusion criteria. Investigators quickly discover that the eligible population is far smaller than expected.<\/p><p>By testing eligibility criteria on simulated populations, predictive models can reveal early whether recruitment assumptions are realistic or whether the protocol needs adjustment before submission.<\/p><h3 class=\"wp-block-heading\">Anticipating protocol deviations<\/h3><p>Protocol deviations are rarely random. They often emerge from procedures that are too complex or poorly aligned with clinical workflows.<\/p><p>Simulating patient and site behavior can highlight steps where compliance is likely to break down. That insight allows sponsors to simplify processes early, reducing operational friction once the trial starts.<\/p><h3 class=\"wp-block-heading\">Smarter safety strategies<\/h3><p>Predictive modeling can also support <strong>risk management planning<\/strong> by identifying where safety signals are most likely to appear.<\/p><p>Rather than collecting excessive safety data everywhere, teams can design more targeted pharmacovigilance strategies, focusing monitoring efforts where they matter most.<\/p><h2 class=\"wp-block-heading\">The real constraint: governance, not technology<\/h2><p>The promise of digital twins is powerful, but it comes with an important caveat.<\/p><p>A model is only as reliable as the <strong>data and governance behind it<\/strong>: without robust data integrity, predictive simulations quickly become theoretical exercises rather than decision-making tools. This is where established regulatory principles remain essential.<\/p><p>Any predictive model used to inform trial design must still align with the same standards that govern clinical evidence generation. That includes principles such as <strong>ALCOA++<\/strong>, ensuring that the underlying data are attributable, legible, contemporaneous, original, accurate, complete, and consistent.<\/p><p>Just as important is <strong>traceability<\/strong>.<br>If a simulation influences a study design decision, regulators must be able to understand:<\/p><ul class=\"wp-block-list\"><li>which data sources were used<\/li>\n\n<li>how the model generated the prediction<\/li>\n\n<li>and why the decision was taken<\/li><\/ul><p>Without this transparency, predictive models risk weakening rather than strengthening the evidence package.<\/p><h2 class=\"wp-block-heading\">Where regulators stand<\/h2><p>Regulatory agencies such as the <strong>European Medicines Agency<\/strong> and the <strong>U.S. Food and Drug Administration<\/strong> are approaching computational models with cautious optimism.<\/p><p>Digital twins are unlikely to replace real patients in pivotal trials anytime soon. However, regulators increasingly recognize the role of <strong>model-informed drug development<\/strong> and other novel methodologies that improve how studies are designed.<\/p><p>This evolution aligns closely with the direction of <strong>ICH E6(R3)<\/strong> and the growing emphasis on <strong>Quality by Design (QbD)<\/strong>. The idea is simple but transformative: quality should not be inspected at the end of a study, it should be engineered into the design from the beginning.<\/p><p>Predictive modeling fits naturally within that philosophy.<\/p><h2 class=\"wp-block-heading\">A shift in how we think about evidence<\/h2><p>As clinical trials become more complex, integrating personalized therapies, digital endpoints, and post-market data, the pressure on study design continues to grow.<\/p><p>In that environment, Digital twins should not be seen as a futuristic gadget borrowed from Silicon Valley. They represent something more fundamental: a <strong>methodological shift<\/strong>.<\/p><p>Instead of reacting to problems during monitoring, we gain the opportunity to <strong>stress-test a study before reality does it for us<\/strong>.<\/p><p>The real question is no longer whether predictive models will become part of clinical research. They already are.<\/p><p>The real question is <strong>how rigorously we build and govern them<\/strong>.<\/p><p>Because behind every simulation, every algorithm, and every predictive output, there must still be the same foundation that has always supported credible science: solid data, transparent methods, and decisions that can stand up to scrutiny.<\/p>","protected":false},"excerpt":{"rendered":"<p>In the past year, Digital twin has become one of the most overused terms in healthcare innovation. It appears in conference slides, CRO strategy decks, and investor presentations, often described as a virtual copy of a patient, ready to be tested like an avatar in a simulation. But the reality is less cinematic and far [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":5025,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[8,11],"class_list":["post-4964","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-clinical-trials","tag-digital-health"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Digital Twins in Clinical Trials: Predictive Study Design<\/title>\n<meta name=\"description\" content=\"Discover digital twins in clinical trials: predictive models for robust study design, risk anticipation, and efficient protocols.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.we4cr.com\/digital-twins-clinical-trials\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Digital Twins in Clinical Trials: Predictive Study Design\" \/>\n<meta property=\"og:description\" content=\"Discover digital twins in clinical trials: predictive models for robust study design, risk anticipation, and efficient protocols.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/we4healthcare.com\/it\/2026\/03\/02\/digital-twins-clinical-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"We4 Healthcare\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-02T10:25:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-24T11:17:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/we4healthcare.com\/wp-content\/uploads\/2026\/03\/female-scientist-using-a-microscope-to-analyze-sam-scaled-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Distributor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"We4 Clinical Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/we4healthcare.com\\\/2026\\\/03\\\/02\\\/digital-twins-clinical-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/we4healthcare.com\\\/2026\\\/03\\\/02\\\/digital-twins-clinical-trials\\\/\"},\"author\":{\"name\":\"Distributor\",\"@id\":\"https:\\\/\\\/we4healthcare.com\\\/#\\\/schema\\\/person\\\/f374b66b3c5841849143d2ecf211c150\"},\"headline\":\"Digital twins in Clinical trials: a new way of designing studies\",\"datePublished\":\"2026-03-02T10:25:41+00:00\",\"dateModified\":\"2026-03-24T11:17:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/we4healthcare.com\\\/2026\\\/03\\\/02\\\/digital-twins-clinical-trials\\\/\"},\"wordCount\":840,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/we4healthcare.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/we4healthcare.com\\\/2026\\\/03\\\/02\\\/digital-twins-clinical-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/we4healthcare.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/female-scientist-using-a-microscope-to-analyze-sam-scaled-1.jpg\",\"keywords\":[\"Clinical Trials\",\"Digital Health\"],\"articleSection\":[\"News\"],\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/we4healthcare.com\\\/2026\\\/03\\\/02\\\/digital-twins-clinical-trials\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/we4healthcare.com\\\/2026\\\/03\\\/02\\\/digital-twins-clinical-trials\\\/\",\"url\":\"https:\\\/\\\/we4healthcare.com\\\/2026\\\/03\\\/02\\\/digital-twins-clinical-trials\\\/\",\"name\":\"Digital Twins in Clinical Trials: Predictive Study Design\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/we4healthcare.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/we4healthcare.com\\\/2026\\\/03\\\/02\\\/digital-twins-clinical-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/we4healthcare.com\\\/2026\\\/03\\\/02\\\/digital-twins-clinical-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/we4healthcare.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/female-scientist-using-a-microscope-to-analyze-sam-scaled-1.jpg\",\"datePublished\":\"2026-03-02T10:25:41+00:00\",\"dateModified\":\"2026-03-24T11:17:05+00:00\",\"description\":\"Discover digital twins in clinical trials: predictive models for robust study design, risk anticipation, and efficient protocols.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/we4healthcare.com\\\/2026\\\/03\\\/02\\\/digital-twins-clinical-trials\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/we4healthcare.com\\\/2026\\\/03\\\/02\\\/digital-twins-clinical-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/we4healthcare.com\\\/2026\\\/03\\\/02\\\/digital-twins-clinical-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/we4healthcare.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/female-scientist-using-a-microscope-to-analyze-sam-scaled-1.jpg\",\"contentUrl\":\"https:\\\/\\\/we4healthcare.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/female-scientist-using-a-microscope-to-analyze-sam-scaled-1.jpg\",\"width\":2560,\"height\":1707},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/we4healthcare.com\\\/2026\\\/03\\\/02\\\/digital-twins-clinical-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/we4healthcare.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Digital twins in Clinical trials: a new way of designing studies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/we4healthcare.com\\\/#website\",\"url\":\"https:\\\/\\\/we4healthcare.com\\\/\",\"name\":\"We4 Healthcare\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/we4healthcare.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/we4healthcare.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/we4healthcare.com\\\/#organization\",\"name\":\"We4 Healthcare\",\"url\":\"https:\\\/\\\/we4healthcare.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/we4healthcare.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/we4healthcare.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/logowe4Healthcare@3x.png\",\"contentUrl\":\"https:\\\/\\\/we4healthcare.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/logowe4Healthcare@3x.png\",\"width\":2400,\"height\":572,\"caption\":\"We4 Healthcare\"},\"image\":{\"@id\":\"https:\\\/\\\/we4healthcare.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/we4healthcare.com\\\/#\\\/schema\\\/person\\\/f374b66b3c5841849143d2ecf211c150\",\"name\":\"Distributor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4c2bb204437517c28aa12ac27472ac3279f3a980bc4fe8a7902baae5e4d235b2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4c2bb204437517c28aa12ac27472ac3279f3a980bc4fe8a7902baae5e4d235b2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4c2bb204437517c28aa12ac27472ac3279f3a980bc4fe8a7902baae5e4d235b2?s=96&d=mm&r=g\",\"caption\":\"Distributor\"},\"url\":\"https:\\\/\\\/www.we4cr.com\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Digital Twins in Clinical Trials: Predictive Study Design","description":"Discover digital twins in clinical trials: predictive models for robust study design, risk anticipation, and efficient protocols.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.we4cr.com\/digital-twins-clinical-trials\/","og_locale":"it_IT","og_type":"article","og_title":"Digital Twins in Clinical Trials: Predictive Study Design","og_description":"Discover digital twins in clinical trials: predictive models for robust study design, risk anticipation, and efficient protocols.","og_url":"https:\/\/we4healthcare.com\/it\/2026\/03\/02\/digital-twins-clinical-trials\/","og_site_name":"We4 Healthcare","article_published_time":"2026-03-02T10:25:41+00:00","article_modified_time":"2026-03-24T11:17:05+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/we4healthcare.com\/wp-content\/uploads\/2026\/03\/female-scientist-using-a-microscope-to-analyze-sam-scaled-1.jpg","type":"image\/jpeg"}],"author":"Distributor","twitter_card":"summary_large_image","twitter_misc":{"Scritto da":"We4 Clinical Research","Tempo di lettura stimato":"4 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/we4healthcare.com\/2026\/03\/02\/digital-twins-clinical-trials\/#article","isPartOf":{"@id":"https:\/\/we4healthcare.com\/2026\/03\/02\/digital-twins-clinical-trials\/"},"author":{"name":"Distributor","@id":"https:\/\/we4healthcare.com\/#\/schema\/person\/f374b66b3c5841849143d2ecf211c150"},"headline":"Digital twins in Clinical trials: a new way of designing studies","datePublished":"2026-03-02T10:25:41+00:00","dateModified":"2026-03-24T11:17:05+00:00","mainEntityOfPage":{"@id":"https:\/\/we4healthcare.com\/2026\/03\/02\/digital-twins-clinical-trials\/"},"wordCount":840,"commentCount":0,"publisher":{"@id":"https:\/\/we4healthcare.com\/#organization"},"image":{"@id":"https:\/\/we4healthcare.com\/2026\/03\/02\/digital-twins-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/we4healthcare.com\/wp-content\/uploads\/2026\/03\/female-scientist-using-a-microscope-to-analyze-sam-scaled-1.jpg","keywords":["Clinical Trials","Digital Health"],"articleSection":["News"],"inLanguage":"it-IT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/we4healthcare.com\/2026\/03\/02\/digital-twins-clinical-trials\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/we4healthcare.com\/2026\/03\/02\/digital-twins-clinical-trials\/","url":"https:\/\/we4healthcare.com\/2026\/03\/02\/digital-twins-clinical-trials\/","name":"Digital Twins in Clinical Trials: Predictive Study Design","isPartOf":{"@id":"https:\/\/we4healthcare.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/we4healthcare.com\/2026\/03\/02\/digital-twins-clinical-trials\/#primaryimage"},"image":{"@id":"https:\/\/we4healthcare.com\/2026\/03\/02\/digital-twins-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/we4healthcare.com\/wp-content\/uploads\/2026\/03\/female-scientist-using-a-microscope-to-analyze-sam-scaled-1.jpg","datePublished":"2026-03-02T10:25:41+00:00","dateModified":"2026-03-24T11:17:05+00:00","description":"Discover digital twins in clinical trials: predictive models for robust study design, risk anticipation, and efficient protocols.","breadcrumb":{"@id":"https:\/\/we4healthcare.com\/2026\/03\/02\/digital-twins-clinical-trials\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/we4healthcare.com\/2026\/03\/02\/digital-twins-clinical-trials\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/we4healthcare.com\/2026\/03\/02\/digital-twins-clinical-trials\/#primaryimage","url":"https:\/\/we4healthcare.com\/wp-content\/uploads\/2026\/03\/female-scientist-using-a-microscope-to-analyze-sam-scaled-1.jpg","contentUrl":"https:\/\/we4healthcare.com\/wp-content\/uploads\/2026\/03\/female-scientist-using-a-microscope-to-analyze-sam-scaled-1.jpg","width":2560,"height":1707},{"@type":"BreadcrumbList","@id":"https:\/\/we4healthcare.com\/2026\/03\/02\/digital-twins-clinical-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/we4healthcare.com\/"},{"@type":"ListItem","position":2,"name":"Digital twins in Clinical trials: a new way of designing studies"}]},{"@type":"WebSite","@id":"https:\/\/we4healthcare.com\/#website","url":"https:\/\/we4healthcare.com\/","name":"We4 Healthcare","description":"","publisher":{"@id":"https:\/\/we4healthcare.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/we4healthcare.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/we4healthcare.com\/#organization","name":"We4 Healthcare","url":"https:\/\/we4healthcare.com\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/we4healthcare.com\/#\/schema\/logo\/image\/","url":"https:\/\/we4healthcare.com\/wp-content\/uploads\/2025\/12\/logowe4Healthcare@3x.png","contentUrl":"https:\/\/we4healthcare.com\/wp-content\/uploads\/2025\/12\/logowe4Healthcare@3x.png","width":2400,"height":572,"caption":"We4 Healthcare"},"image":{"@id":"https:\/\/we4healthcare.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/we4healthcare.com\/#\/schema\/person\/f374b66b3c5841849143d2ecf211c150","name":"Distributor","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/secure.gravatar.com\/avatar\/4c2bb204437517c28aa12ac27472ac3279f3a980bc4fe8a7902baae5e4d235b2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4c2bb204437517c28aa12ac27472ac3279f3a980bc4fe8a7902baae5e4d235b2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4c2bb204437517c28aa12ac27472ac3279f3a980bc4fe8a7902baae5e4d235b2?s=96&d=mm&r=g","caption":"Distributor"},"url":"https:\/\/www.we4cr.com"}]}},"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"We4 Clinical Research","distributor_original_site_url":"https:\/\/www.we4cr.com","push-errors":false,"_links":{"self":[{"href":"https:\/\/we4healthcare.com\/it\/wp-json\/wp\/v2\/posts\/4964","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/we4healthcare.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/we4healthcare.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/we4healthcare.com\/it\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/we4healthcare.com\/it\/wp-json\/wp\/v2\/comments?post=4964"}],"version-history":[{"count":1,"href":"https:\/\/we4healthcare.com\/it\/wp-json\/wp\/v2\/posts\/4964\/revisions"}],"predecessor-version":[{"id":5024,"href":"https:\/\/we4healthcare.com\/it\/wp-json\/wp\/v2\/posts\/4964\/revisions\/5024"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/we4healthcare.com\/it\/wp-json\/wp\/v2\/media\/5025"}],"wp:attachment":[{"href":"https:\/\/we4healthcare.com\/it\/wp-json\/wp\/v2\/media?parent=4964"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/we4healthcare.com\/it\/wp-json\/wp\/v2\/categories?post=4964"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/we4healthcare.com\/it\/wp-json\/wp\/v2\/tags?post=4964"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}